What type of study is this?

October 3, 2025CancersOpen Access

Co-Stimulatory and Immune Checkpoint Molecule Expression on Peripheral Immune Cells Differs Age Dependently Between Healthy Donors and Patients with Head and Neck Squamous Cell Carcinoma

View Full Paper

Ask AI

Bookmark

Increased immune checkpoint molecule expression is associated with age in patients with head and neck squamous cell carcinoma.
Healthy donors show decreased expression of immune checkpoint molecules as age increases.
Flow cytometry analysis of peripheral blood mononuclear cells reveals significant findings in co-stimulatory molecule expression.
This study highlights the importance of age in developing individualized immune checkpoint inhibition therapies for HNSCC.

No takes yet. Share an insight, caveat, or question.

Analysis shows variations in immune checkpoint molecules and co-stimulatory expression in HNSCC patients, suggesting age influences immune responses.

Puntigam et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

Analysis shows variations in immune checkpoint molecules and co-stimulatory expression in HNSCC patients, suggesting age influences immune responses.